Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Rural New Mexico hospital may close its doors after $100M malpractice judgment

Rehoboth McKinley Medical Center lost a 2019 malpractice case involving a botched hernia surgery. The hospital was already operating at a loss before the case went to court.

FDA announces recall of Optum infusion pumps over risk of serious malfunctions

The Nimbus II Plus infusion pumps are being recalled due to multiple malfunctions that could put patients at risk.

wallet purse broke bankrupt

Rising cost of private insurance unsustainable for 180 million families, study finds

The average cost of care for families covered by private insurance increased from $3,920 to $4,907 between 2007 and 2019.

Lawsuit filed in response to $43B nursing home staffing rule

Nursing home groups are suing CMS to block a final rule that mandates staffing and direct care minimums.

Private equity-owned birthing centers in Florida back c-section rule change

The state will now allow cesarean sections to be performed outside of a hospital setting.

Money bankruptcy debt liquidation

Private equity investment in healthcare down 20% as regulatory pressures mount

Public sentiment has turned against private equity stakeholders in healthcare, and that isn't likely to change post-election.

Thumbnail

Florida health network sued for sharing PHI with Facebook

Palm Beach Health Network is accused of using Meta’s Pixel code on its website, which gathers data on patients and sends it to advertisers.

abortion law ban pregnancy dobbs

Fewer doctors want to work in states where abortion is illegal

In states where abortion is outlawed, the number of new MDs applying to residencies dropped 4.2% since last year, an analysis from the AAMC finds.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.